WR1 General Discussion, page-13645

That sounds about right. For whatever reason, though, the punters aren't likely to go into a sustained buying frenzy on the strength of such (very good) results. It seems to me as though PMET has set a new benchmark that has made almost everyone else look very second rate in the eyes of the punters. They want blood and nothing less. I just wonder if they'll be satisfied with a MRE of >50Mt, given that they probably figure PMET will post >100Mt. But then I see some of these other companies with thin deep intersections being well supported by punters, so I can't work it out. What I'm really hoping for is something truly outstanding from Cancet to catch the market's eye. Let's hope there's something of that description amongst the 40 cores at the lab now.